Cargando…
The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air
COVID-19, caused by a novel coronavirus, SARS-CoV-2, contributes significantly to the morbidity and mortality in humans worldwide. In the absence of specific vaccines or therapeutics available, COVID-19 cases are managed empirically with the passive immunity approach and repurposing of drugs used fo...
Autores principales: | Gopalaswamy, Radha, Ganesan, Natarajan, Velmurugan, Kalamani, Aravindhan, Vivekanandhan, Subbian, Selvakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711751/ https://www.ncbi.nlm.nih.gov/pubmed/33081331 http://dx.doi.org/10.3390/vaccines8040612 |
Ejemplares similares
-
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
por: Gopalaswamy, Radha, et al.
Publicado: (2021) -
The BCG Vaccine for COVID-19: First Verdict and Future Directions
por: Gonzalez-Perez, Maria, et al.
Publicado: (2021) -
Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment
por: Gopalaswamy, Radha, et al.
Publicado: (2020) -
The Commissioner's Summing-Up, and the Verdict
Publicado: (1852) -
The Informed Verdict
Publicado: (1918)